Australia - English - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - felodipine, quantity: 5 mg - tablet, modified release - excipient ingredients: aluminium sodium silicate; sodium stearylfumarate; propyl gallate; lactose; hyprolose; titanium dioxide; hypromellose; iron oxide yellow; microcrystalline cellulose; iron oxide red; carnauba wax; peg-40 hydrogenated castor oil; macrogol 6000 - hypertension.

Australia - English - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - felodipine, quantity: 5 mg - tablet, modified release - excipient ingredients: carnauba wax; hypromellose; iron oxide red; propyl gallate; macrogol 6000; microcrystalline cellulose; sodium stearylfumarate; iron oxide yellow; lactose; titanium dioxide; peg-40 hydrogenated castor oil; hyprolose; aluminium sodium silicate - hypertension

Malta - English - Medicines Authority

astrazeneca ab se-151 85, södertälje, sweden - felodipine - prolonged-release tablet - felodipine 5 mg - calcium channel blockers

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

recordati ireland ltd. - metoprolol succinate 47,5 mg; felodipine 5 mg - prolonged-release tablet - 5 mg - 47,5 mg - felodipine 5 mg; metoprolol succinate 47.5 mg - metoprolol and other antihypertensives

United States - English - NLM (National Library of Medicine)

a-s medication solutions - felodipine (unii: ol961r6o2c) (felodipine - unii:ol961r6o2c) - felodipine 10 mg - felodipine extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including felodipine. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than 1 drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacologic classes an

Ireland - English - HPRA (Health Products Regulatory Authority)

imbat limited - ramipril; felodipine - prolonged-release tablet - 5/5 mg/mg - ace inhibitors and calcium channel blockers; ramipril and felodipine

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - felodipine (unii: ol961r6o2c) (felodipine - unii:ol961r6o2c) - felodipine 2.5 mg - felodipine extended-release tablets are indicated for the treatment of hypertension. felodipine extended-release tablets may be used alone or concomitantly with other antihypertensive agents. felodipine extended-release tablets are contraindicated in patients who are hypersensitive to this product. safety and effectiveness in pediatric patients have not been established. clinical studies of felodipine did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. other reported clinical experience has not identified differences in responses between the elderly and younger patients. pharmacokinetics, however, indicate that the availability of felodipine is increased in older patients (see clinical pharmacology: geriatric use). in general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of conco

United States - English - NLM (National Library of Medicine)

carilion materials management - felodipine (unii: ol961r6o2c) (felodipine - unii:ol961r6o2c) - felodipine 2.5 mg - felodipine extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including felodipine. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than 1 drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacologic classes an

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - felodipine; ramipril - modified-release tablet - 2.5mg ; 2.5mg

Ireland - English - HPRA (Health Products Regulatory Authority)

selana healthcare ltd - felodipine - tablet prolonged release - 5 milligram